These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2465265)

  • 1. Immunotherapy of genital warts with inosine pranobex and conventional treatment: double blind placebo controlled study.
    Davidson-Parker J; Dinsmore W; Khan MH; Hicks DA; Morris CA; Morris DF
    Genitourin Med; 1988 Dec; 64(6):383-6. PubMed ID: 2465265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of genital warts with inosine pranobex (Imunovir): preliminary study.
    Mohanty KC; Scott CS
    Genitourin Med; 1986 Oct; 62(5):352-5. PubMed ID: 2429908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis.
    Brzeski M; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1990 May; 49(5):293-5. PubMed ID: 1693065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of frequently recurring genital herpes: acyclovir v inosine pranobex.
    Mindel A; Carney O; Sonnex C; Freris M; Patou G; Williams P
    Genitourin Med; 1989 Apr; 65(2):103-5. PubMed ID: 2473952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoprinosine in the treatment of genital warts.
    O'Neill BB; Robins DS
    Cancer Detect Prev; 1988; 12(1-6):497-501. PubMed ID: 2460237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of first-attack genital herpes--acyclovir versus inosine pranobex.
    Mindel A; Kinghorn G; Allason-Jones E; Woolley P; Barton I; Faherty A; Jeavons M; Williams P; Patou G
    Lancet; 1987 May; 1(8543):1171-3. PubMed ID: 2437417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study.
    Beran J; Šalapová E; Špajdel M;
    BMC Infect Dis; 2016 Nov; 16(1):648. PubMed ID: 27821093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Double-blind clinical trial of isoprinosine and placebo in herpetic keratitis].
    Haut J; Debrat G; Moulin F; Monin C; Sarnikovski C
    Bull Soc Ophtalmol Fr; 1983 May; 83(5):617-20. PubMed ID: 6200245
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative studies of inosine pranobex and acyclovir.
    Mindel A
    Am J Med; 1988 Aug; 85(2A):7-9. PubMed ID: 2457315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.
    Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO; Nielsen JO
    N Engl J Med; 1990 Jun; 322(25):1757-63. PubMed ID: 1693173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients.
    You Y; Wang L; Li Y; Wang Q; Cao S; Tu Y; Li S; Bai L; Lu J; Wei Z; Chen W; Hao F
    J Dermatol; 2015 Jun; 42(6):596-601. PubMed ID: 25819042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised, double-blind, parallel group study to compare subcutaneous interferon alpha-2a plus podophyllin with placebo plus podophyllin in the treatment of primary condylomata acuminata.
    Armstrong DK; Maw RD; Dinsmore WW; Morrison GD; Pattman RS; Watson PG; Nathan PM; Moss T; Nayagam A; Wade A
    Genitourin Med; 1994 Dec; 70(6):389-93. PubMed ID: 7705855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind clinical trial of the effects of inosine pranobex in immunodepressed patients with prolonged generalized lymphadenopathy.
    Wallace JI; Bekesi JG
    Clin Immunol Immunopathol; 1986 Apr; 39(1):179-86. PubMed ID: 2419019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isoprinosine in acute viral hepatitis type A. Preliminary report].
    Welch E; Rubio S; Guerrero J; Ceresa S; Las Heras J; Godoy MA
    Rev Chil Pediatr; 1982; 53(3):213-7. PubMed ID: 6185974
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effectiveness of commonly used clinic-based treatments for external genital warts.
    Sherrard J; Riddell L
    Int J STD AIDS; 2007 Jun; 18(6):365-8. PubMed ID: 17609022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of anogenital warts. Comparison of trichloracetic acid and podophyllin versus podophyllin alone.
    Gabriel G; Thin RN
    Br J Vener Dis; 1983 Apr; 59(2):124-6. PubMed ID: 6338998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of topical methisoprinol (Viruxan) in female genital condylomatosis].
    Penna C; Fallani MG; Cariti G; Menichetti M; Bracco GL; Bellanti G; Cioffi M; Marchionni M
    Minerva Ginecol; 1989 Jan; 41(1):27-32. PubMed ID: 2472583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of inosine pranobex oral therapy in subclinical human papillomavirus infection of the vulva: a randomized double-blinded placebo controlled study.
    Tay SK
    Int J STD AIDS; 1996 Jul; 7(4):276-80. PubMed ID: 8876359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of condylomatous lesions with isoprinosine compared to a non-treated control group. Multicenter study].
    Amadio E; Beauchamp GP; Berget-Pauquet ; Brendel MC; Cossard F; Daguin-Dimeglio ML; Dalbos D; Devaure Y; de Granvilliers-Quellien MN; Grelet C
    Rev Fr Gynecol Obstet; 1986 Nov; 81(11):643-50. PubMed ID: 2432645
    [No Abstract]   [Full Text] [Related]  

  • 20. Inosine pranobex--only for use in controlled trials.
    Drug Ther Bull; 1986 Dec; 24(24):95-6. PubMed ID: 2433117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.